FAS and autoimmune lymphoproliferative syndrome: In our opinion, a targeted gene panel would be an appropriate initial genetic approach for patients with ALPS suspicion, since it has the advantage of covering germinal mutations in FAS (and other ALPS-related genes) and it may detect somatic variants in some cases.